FTSE 100 notches fourth straight day of gains as oil slides on US-Iran deal hopes

By Reuters News

- Britain's FTSE 100 rose for the fourth straight day on Monday as a sharp drop in oil prices lifted broader risk appetite, with investors awaiting the Bank of England's interest rate decision this week.

The blue-chip FTSE 100 index .FTSE ended up 0.3% at 10,761.33 points, while the midcap FTSE 250 .FTMC climbed 1.4% to 24,795.85.

  • Oil prices slumped 7.5% with Brent crude trading around $104 a barrel, as talks between Iran and Qatar raised hopes of an end to the US-Iran war O/R

  • The energy sector .FTNMX601010 fell 3.3%, with Ithaca Energy ITH.L down 6%, while BP BP.L fell 4.4% and 2.9%, respectively, among the bottom performers on the FTSE 100

  • Broader gains were led by the FTSE 350 travel & leisure index .FTUB4050, up 2.7%, the construction & materials index .FTUB5010, up 2.8%, and the consumer products & services index .FTUB4020, up 2.5%

  • Pharma stocks .FTNMX201030 declined 0.7% after gaining over 5% on Friday, their biggest single-day gain in about 13 months

  • The Bank of England's interest rate decision will be in focus on Thursday, with the central bank widely expected to raise rates by 25 basis points for the first time in three years

  • Higher-than-expected inflation in September sealed the case for tighter monetary policy. It was underscored by data on Monday showing British manufacturers recorded their strongest output growth in more than two years in October

  • The FTSE 100 marked its first monthly gain in three months in October, outperforming the US benchmark S&P 500 that lost close to 1% due to a selloff in AI stocks

  • Finance minister John Healey's first budget last week presented less-severe-than-expected tax hikes on banks and gambling firms as well as funding for Britain's defence plan, sparking a rally in those stocks

  • Public transport operator FirstGroup FGP.L rose 7% after agreeing to sell certain assets to the West Yorkshire Combined Authority for £109 million ($145.95 million), helping support the midcap index

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.